Literature DB >> 17129413

Nitric oxide synthase expressions in ADR-induced cardiomyopathy in rats.

Baogang Liu1, Hongli Li, Hongyan Qu, Baogui Sun.   

Abstract

In this study, we investigate Nitric oxide synthase (NOS) expressions in adriamycin (ADR)-induced cadiomyopathy in rats. Sixty male Wistar rats were randomly divided into two main groups: control and ADR groups. Myocardial histopathological observation was performed; Expressions of 3 isoforms of NOS genes were examined by RT-PCR analysis; Expressions of 3 isoforms of NOS protein was assessed by Western blot analysis. Myocardium exhibited intensive morphological changes after 8 weeks of ADR treatment. The expression levels of inducible NOS (iNOS) gene and protein were significantly increased in ADRtreated rats after 8 weeks of treatment and then slightly increased at weeks 9 and 10. No significantly difference of neuronal NOS (nNOS) or endothelial NOS (eNOS) gene and protein were observed in the myocardium obtained from the control rats and ADR-injected rats at any time point. iNOS gene expression is selectively induced by ADR in heart. The upregulation of iNOS gene and protein may be somehow correlated with morphological changes seen in heart of rat treated with ADR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17129413     DOI: 10.5483/bmbrep.2006.39.6.759

Source DB:  PubMed          Journal:  J Biochem Mol Biol        ISSN: 1225-8687


  9 in total

Review 1.  Doxorubicin-Induced Cardiomyopathy in Children.

Authors:  Trevi R Mancilla; Brian Iskra; Gregory J Aune
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

2.  Catechin protects against oxidative stress and inflammatory-mediated cardiotoxicity in adriamycin-treated rats.

Authors:  Tarek A Abd El-Aziz; Randa H Mohamed; Heba F Pasha; Hisham R Abdel-Aziz
Journal:  Clin Exp Med       Date:  2011-11-12       Impact factor: 3.984

3.  Protection from doxorubicin-induced cardiomyopathy using the modified anthracycline N-benzyladriamycin-14-valerate (AD 198).

Authors:  Chun Cai; Leonard Lothstein; R Ray Morrison; Polly A Hofmann
Journal:  J Pharmacol Exp Ther       Date:  2010-07-28       Impact factor: 4.030

4.  Effect of Shengmai injection () on diaphragmatic contractility in doxorubicin-treated rats.

Authors:  Min Ge; Ying-yan Fang; Guo-ping Liu; Su-dong Guan
Journal:  Chin J Integr Med       Date:  2012-08-18       Impact factor: 1.978

5.  Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.

Authors:  Partha Mukhopadhyay; Mohanraj Rajesh; Sándor Bátkai; Yoshihiro Kashiwaya; György Haskó; Lucas Liaudet; Csaba Szabó; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

Review 6.  Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity.

Authors:  Donato Cappetta; Antonella De Angelis; Luigi Sapio; Lucia Prezioso; Michela Illiano; Federico Quaini; Francesco Rossi; Liberato Berrino; Silvio Naviglio; Konrad Urbanek
Journal:  Oxid Med Cell Longev       Date:  2017-10-18       Impact factor: 6.543

Review 7.  Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress.

Authors:  Paweorn Angsutararux; Sudjit Luanpitpong; Surapol Issaragrisil
Journal:  Oxid Med Cell Longev       Date:  2015-09-29       Impact factor: 6.543

Review 8.  Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines.

Authors:  Derek W Edwardson; Rashmi Narendrula; Simon Chewchuk; Kyle Mispel-Beyer; Jonathan P J Mapletoft; Amadeo M Parissenti
Journal:  Curr Drug Metab       Date:  2015       Impact factor: 3.731

Review 9.  Anthracycline-Related Heart Failure: Certain Knowledge and Open Questions : Where Do we Stand with Chemotherapyinduced Cardiotoxicity?

Authors:  Emma Louise Robinson; Maral Azodi; Stephane Heymans; Ward Heggermont
Journal:  Curr Heart Fail Rep       Date:  2020-09-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.